Cargando…
Cognitive Behavioral Therapy for Treatment-Related Fatigue in Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitors: A Mixed-Method Study
Treatment-related fatigue significantly limits quality of life among chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitors (TKIs), yet no interventions to reduce this symptom have been studied. We examined preliminary feasibility and efficacy of cognitive behavioral therapy fo...
Autores principales: | Poort, Hanneke, Onghena, Patrick, Abrahams, Harriët J. G., Jim, Heather S. L., Jacobsen, Paul B., Blijlevens, Nicole M. A., Knoop, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851212/ https://www.ncbi.nlm.nih.gov/pubmed/30747340 http://dx.doi.org/10.1007/s10880-019-09607-5 |
Ejemplares similares
-
Fatigue in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy: predictors and the relationship with physical activity
por: Janssen, Lando, et al.
Publicado: (2020) -
Transporter-Mediated Cellular Distribution of Tyrosine Kinase Inhibitors as a Potential Resistance Mechanism in Chronic Myeloid Leukemia
por: Verhagen, Noor E., et al.
Publicado: (2023) -
Skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia
por: Janssen, L., et al.
Publicado: (2019) -
Potential mechanisms of the fatigue‐reducing effect of cognitive‐behavioral therapy in cancer survivors: Three randomized controlled trials
por: Müller, Fabiola, et al.
Publicado: (2021) -
The Impact of Tyrosine Kinase Inhibitors on Fatherhood in Patients With Chronic Myeloid Leukemia: A Mixed-Method Study
por: Abu-Tineh, Mohammad, et al.
Publicado: (2023)